Upcoming Events:

Recent Events:
BioEurope, Düsseldorf, 2011
NeuroScience, San Diego, November 13-17
R&D Leaders Forum, Boston, November 8-10
ICAD, Honolulu, Juli 9-15
EPIC, London, Juni 23
BIO, Chicago, May 3-6
Sachs Forum, Zürich, Feb. 10-12
BioBusiness 2010, London, Jan. 18-20
BioEurope 2009, November 2-4 in Vienna, Austria
ICAD, July 11-16 in Vienna, Austria
BioPartnering Europe 2009, October 11-13 in London, UK
BioPharm America, September 16-18 in San Francisco, USA
Swiss Exchange Convention Point, September 14-15 in Zurich, Switzerland
CNS Clinical Trials, June 2.-3. in Brussels, Belgium
BioBusiness, February 17-18, 2009 - Geneva, Switzerland

Press releases

Galantos Pharma Raises € 4.4 Million to Advance its Alzheimer`s Dementia Strategy.
Mainz, Germany, April 30, 2010. Galantos Pharma announced today the successful finalization of its C financing round to bring its leading compound Memogain® for Alzheimer’s Dementia (AD) into the clinic and to develop novel neuroprotective AD compounds.
Download Press Release 30.04.2010:
Galantos Pharma PR english / Galantos Pharma PR deutsch

Galantos Pharma receives government grant for the development
of novel drugs against Alzheimer's Disease
Public funding by BMBF speeds up Company’s ambitious preclinical program
Download Press Release 6.07.2009:
Galantos Pharma PR english / Galantos Pharma PR deutsch

Galantos Pharma Receives Research Grant
Expansion of technology platform
Download Press Release 28.05.2008:
Galantos Pharma PR english / Galantos Pharma PR deutsch

Galantos Pharma Selects Candidate for Clinical
Development in Alzheimer’s Disease
Milestone triggers payment of last tranche of Series B financing round
Download Press Release 26.03.2008:
Galantos Pharma PR english / Galantos Pharma PR deutsch

Galantos Pharma Finalized B-Financing Round Oktober 2007
Download Press Release Oktober 2007:
Galantos Pharma PR english / Galantos Pharma deutsch

Galantos Pharma gibt die Einwerbung von € 500.000 Risikokapital vom High-Tech Gründerfonds und € 100.000 vom FIB Fonds Rheinland-Pfalz für die Entwicklung neuartiger Arzneimittel gegen die Alzheimer’sche Demenz bekannt.
Download Press Release März 2007:
Galantos und High-Tech Gründerfonds März 2006

Download: 
  Press Release February 2006

Galantos Pharma GmbH, Mainz
Download:  Firmeninformationen 2006

Galantos Pharma - Entwicklung von Arzneimitteln für
Demenzerkrankungen des Alters
Download: Unternehmensinnovation 2006